These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

468 related items for PubMed ID: 29096656

  • 1. Liver resection for hepatocellular carcinoma in patients with hematological malignancies.
    Lin HC, Yang YS, Teng CJ, Shen CH, Jan YG, Cheng SB, Wu CC, Lin YL, Huang CC, P'eng FK.
    World J Surg Oncol; 2017 Nov 02; 15(1):194. PubMed ID: 29096656
    [Abstract] [Full Text] [Related]

  • 2. Clinical efficacy of postoperative adjuvant transcatheter arterial chemoembolization on hepatocellular carcinoma.
    Liu C, Sun L, Xu J, Zhao Y.
    World J Surg Oncol; 2016 Apr 02; 14():100. PubMed ID: 27038790
    [Abstract] [Full Text] [Related]

  • 3. Impact of viral hepatitis on outcomes after liver resection for hepatocellular carcinoma: results from a north american center.
    Lee JJ, Kim PT, Fischer S, Fung S, Gallinger S, McGilvray I, Moulton CA, Wei AC, Greig PD, Cleary SP.
    Ann Surg Oncol; 2014 Aug 02; 21(8):2708-16. PubMed ID: 24806113
    [Abstract] [Full Text] [Related]

  • 4. Clinicopathological features of hepatocellular carcinomas (HCCs) arising in patients without chronic viral infection or alcohol abuse: a retrospective study of patients undergoing hepatic resection.
    Yokoi Y, Suzuki S, Baba S, Inaba K, Konno H, Nakamura S.
    J Gastroenterol; 2005 Mar 02; 40(3):274-82. PubMed ID: 15830287
    [Abstract] [Full Text] [Related]

  • 5. Advanced Recurrent Hepatocellular Carcinoma: Treatment with Sorafenib Alone or in Combination with Transarterial Chemoembolization and Radiofrequency Ablation.
    Peng Z, Chen S, Wei M, Lin M, Jiang C, Mei J, Li B, Wang Y, Li J, Xie X, Chen M, Qian G, Kuang M.
    Radiology; 2018 May 02; 287(2):705-714. PubMed ID: 29390197
    [Abstract] [Full Text] [Related]

  • 6. Adjuvant sorafenib after heptectomy for Barcelona Clinic Liver Cancer-stage C hepatocellular carcinoma patients.
    Xia F, Wu LL, Lau WY, Huan HB, Wen XD, Ma KS, Li XW, Bie P.
    World J Gastroenterol; 2016 Jun 21; 22(23):5384-92. PubMed ID: 27340354
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Postoperative Outcomes for Patients with Non-B Non-C Hepatocellular Carcinoma: A Subgroup Analysis of Patients with a History of Hepatitis B Infection.
    Omichi K, Shindoh J, Yamamoto S, Matsuyama Y, Akamatsu N, Arita J, Kaneko J, Sakamoto Y, Hasegawa K, Kokudo N.
    Ann Surg Oncol; 2015 Dec 21; 22 Suppl 3():S1034-40. PubMed ID: 26350363
    [Abstract] [Full Text] [Related]

  • 9. Current management of hepatocellular carcinoma.
    Mendizabal M, Reddy KR.
    Med Clin North Am; 2009 Jul 21; 93(4):885-900, viii. PubMed ID: 19577120
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Combined hepatocellular carcinoma and cholangiocarcinoma: clinical features, treatment modalities, and prognosis.
    Yin X, Zhang BH, Qiu SJ, Ren ZG, Zhou J, Chen XH, Zhou Y, Fan J.
    Ann Surg Oncol; 2012 Sep 21; 19(9):2869-76. PubMed ID: 22451237
    [Abstract] [Full Text] [Related]

  • 12. Surgical results in patients with dual hepatitis B- and C-related hepatocellular carcinoma compared with hepatitis B- or C-related hepatocellular carcinoma.
    Chen MF, Jeng LB, Lee WC, Chen TC.
    Surgery; 1998 May 21; 123(5):554-9. PubMed ID: 9591008
    [Abstract] [Full Text] [Related]

  • 13. Management of hepatocellular carcinoma: an overview of major findings from meta-analyses.
    Qi X, Zhao Y, Li H, Guo X, Han G.
    Oncotarget; 2016 Jun 07; 7(23):34703-51. PubMed ID: 27167195
    [Abstract] [Full Text] [Related]

  • 14. Practical Considerations of Real Life of Hepatocellular Carcinoma in a Tertiary Center of Brazil.
    Almeida-Carvalho SR, Gomes-Ferraz ML, Loureiro-Matos CA, Benedito-Silva AT, Carvalho-Filho RJ, Renato-Perez R, Miziara-Gonzalez A, Salzedas-Netto AA, Szejnfeld D, D'Ippolito G, Pereira-Lanzoni V, Souza-Silva I.
    Ann Hepatol; 2017 Jun 07; 16(2):255-262. PubMed ID: 28233747
    [Abstract] [Full Text] [Related]

  • 15. Changing trends in long-term outcomes after hepatic resection for hepatocellular carcinoma: A 30-year, single-center experience.
    Yamamoto Y, Ikoma H, Morimura R, Konishi H, Murayama Y, Komatsu S, Shiozaki A, Kuriu Y, Kubota T, Nakanishi M, Ichikawa D, Fujiwara H, Okamoto K, Sakakura C, Ochiai T, Otsuji E.
    Anticancer Res; 2013 Nov 07; 33(11):5097-105. PubMed ID: 24222155
    [Abstract] [Full Text] [Related]

  • 16. Hepatocellular carcinoma cases with high levels of c-Raf-1 expression may benefit from postoperative adjuvant sorafenib after hepatic resection even with high risk of recurrence.
    Lei J, Zhong J, Hao J, Liu Z, Zhang P, Wu L, Yan L, Zhu J, Zeng Y, Li B, Wen T, Wang W.
    Oncotarget; 2016 Jul 05; 7(27):42598-42607. PubMed ID: 26981887
    [Abstract] [Full Text] [Related]

  • 17. Suppressive effects of entecavir on hepatitis B virus and hepatocellular carcinoma.
    Jin YJ, Shim JH, Lee HC, Yoo DJ, Kim KM, Lim YS, Suh DJ.
    J Gastroenterol Hepatol; 2011 Sep 05; 26(9):1380-8. PubMed ID: 21884247
    [Abstract] [Full Text] [Related]

  • 18. Adjuvant sorafenib for hepatocellular carcinoma after resection or ablation (STORM): a phase 3, randomised, double-blind, placebo-controlled trial.
    Bruix J, Takayama T, Mazzaferro V, Chau GY, Yang J, Kudo M, Cai J, Poon RT, Han KH, Tak WY, Lee HC, Song T, Roayaie S, Bolondi L, Lee KS, Makuuchi M, Souza F, Berre MA, Meinhardt G, Llovet JM, STORM investigators.
    Lancet Oncol; 2015 Oct 05; 16(13):1344-54. PubMed ID: 26361969
    [Abstract] [Full Text] [Related]

  • 19. Prognosis after resection of hepatitis B virus-related hepatocellular carcinoma originating from non-cirrhotic liver.
    Zhou YM, Zhang XF, Li B, Sui CJ, Yang JM.
    Ann Surg Oncol; 2014 Jul 05; 21(7):2406-12. PubMed ID: 24577811
    [Abstract] [Full Text] [Related]

  • 20. Outcomes after curative hepatectomy in patients with non-B non-C hepatocellular carcinoma and hepatitis B virus hepatocellular carcinoma from non-cirrhotic liver.
    Kim JM, Kwon CH, Joh JW, Park JB, Lee JH, Kim SJ, Paik SW, Park CK, Yoo BC.
    J Surg Oncol; 2014 Dec 05; 110(8):976-81. PubMed ID: 25171344
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.